A Study of a Personalized Neoantigen Cancer Vaccine
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
The purpose of this study is to evaluate the safety, dose, immunogenicity and early clinical activity of GRT-C901 and GRT-R902, a personalized neoantigen cancer vaccine, in combination with nivolumab and ipilimumab, in patients with metastatic non-small cell lung cancer, microsatellite stable colorectal cancer, gastroesophageal adenocarcinoma, and metastatic urothelial cancer.
创建时间：
2019-02-15
